about
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include S...
Read More
1.76
0.02
(1.15%)
3.1M
XNAS Volume
XNAS 08 Aug, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Gossamer Bio Inc is on 12 Aug 2025 for the purpose of Gossamer Bio Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Gossamer Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..